INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to 1ISRG. 1ISRG was compared to 64 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG is valued quite expensive, but it does show an excellent growth. This makes 1ISRG very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
1ISRG had positive earnings in the past year.
In the past year 1ISRG had a positive cash flow from operations.
Each year in the past 5 years 1ISRG has been profitable.
In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 12.88%, 1ISRG belongs to the best of the industry, outperforming 90.63% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.47%, 1ISRG is in the better half of the industry, outperforming 79.69% of the companies in the same industry.
The Return On Invested Capital of 1ISRG (10.45%) is better than 81.25% of its industry peers.
1ISRG had an Average Return On Invested Capital over the past 3 years of 10.24%. This is in line with the industry average of 8.65%.
The 3 year average ROIC (10.24%) for 1ISRG is below the current ROIC(10.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROIC | 10.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1.3 Margins
1ISRG has a Profit Margin of 28.41%. This is amongst the best in the industry. 1ISRG outperforms 93.75% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a Operating Margin of 28.28%. This is amongst the best in the industry. 1ISRG outperforms 96.88% of its industry peers.
1ISRG's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 67.09%, 1ISRG is doing good in the industry, outperforming 67.19% of the companies in the same industry.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% |
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
1ISRG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
1ISRG has an Altman-Z score of 58.57. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of 1ISRG (58.57) is better than 100.00% of its industry peers.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 58.57 |
ROIC/WACC1.14
WACC9.15%
2.3 Liquidity
A Current Ratio of 4.98 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG's Current ratio of 4.98 is amongst the best of the industry. 1ISRG outperforms 93.75% of its industry peers.
A Quick Ratio of 3.97 indicates that 1ISRG has no problem at all paying its short term obligations.
The Quick ratio of 1ISRG (3.97) is better than 95.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 |
3. Growth
3.1 Past
1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.76%, which is quite impressive.
Measured over the past years, 1ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
Looking at the last year, 1ISRG shows a quite strong growth in Revenue. The Revenue has grown by 19.08% in the last year.
1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.45% on average per year.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1ISRG is valuated quite expensively with a Price/Earnings ratio of 73.02.
Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
When comparing the Price/Earnings ratio of 1ISRG to the average of the S&P500 Index (26.53), we can say 1ISRG is valued expensively.
1ISRG is valuated quite expensively with a Price/Forward Earnings ratio of 60.51.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than 64.06% of the companies in the same industry.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 22.27, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.02 | ||
| Fwd PE | 60.51 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 65.63% of the companies listed in the same industry.
1ISRG's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 114.64 | ||
| EV/EBITDA | 64.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ISRG has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 13.88% in the coming years.
PEG (NY)8.26
PEG (5Y)6.36
EPS Next 2Y12.18%
EPS Next 3Y13.88%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (5/29/2025, 7:00:00 PM)
489.25
-10.2 (-2.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap175.36B
Analysts79.49
Price Target526.29 (7.57%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.91%
Min EPS beat(2)3.05%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)11.89%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.01%
EPS beat(12)10
Avg EPS beat(12)4.94%
EPS beat(16)13
Avg EPS beat(16)5.44%
Revenue beat(2)2
Avg Revenue beat(2)3.11%
Min Revenue beat(2)1.09%
Max Revenue beat(2)5.12%
Revenue beat(4)2
Avg Revenue beat(4)1.5%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)0.86%
PT rev (1m)2.47%
PT rev (3m)-15.2%
EPS NQ rev (1m)-2%
EPS NQ rev (3m)-2.19%
EPS NY rev (1m)-2.89%
EPS NY rev (3m)-2.85%
Revenue NQ rev (1m)0.25%
Revenue NQ rev (3m)0.29%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 73.02 | ||
| Fwd PE | 60.51 | ||
| P/S | 22.96 | ||
| P/FCF | 114.64 | ||
| P/OCF | 73.26 | ||
| P/B | 11.7 | ||
| P/tB | 11.95 | ||
| EV/EBITDA | 64.55 |
EPS(TTM)6.7
EY1.37%
EPS(NY)8.08
Fwd EY1.65%
FCF(TTM)4.27
FCFY0.87%
OCF(TTM)6.68
OCFY1.37%
SpS21.31
BVpS41.83
TBVpS40.93
PEG (NY)8.26
PEG (5Y)6.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.88% | ||
| ROE | 14.47% | ||
| ROCE | 13.94% | ||
| ROIC | 10.45% | ||
| ROICexc | 14.17% | ||
| ROICexgc | 14.58% | ||
| OM | 28.28% | ||
| PM (TTM) | 28.41% | ||
| GM | 67.09% | ||
| FCFM | 20.03% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 185.49% | ||
| Cap/Sales | 11.31% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.16% | ||
| Profit Quality | 70.49% | ||
| Current Ratio | 4.98 | ||
| Quick Ratio | 3.97 | ||
| Altman-Z | 58.57 |
F-Score6
WACC9.15%
ROIC/WACC1.14
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y8.84%
EPS Next 2Y12.18%
EPS Next 3Y13.88%
EPS Next 5Y14.45%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year18.08%
Revenue Next 2Y16.61%
Revenue Next 3Y16.15%
Revenue Next 5Y14.12%
EBIT growth 1Y32.36%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year33.95%
EBIT Next 3Y22.85%
EBIT Next 5Y19.86%
FCF growth 1Y73.18%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y66.62%
OCF growth 3Y4.95%
OCF growth 5Y8.61%